LEADER 01848nam 2200373 450 001 9910688467403321 005 20230630170344.0 035 $a(CKB)5400000000040854 035 $a(NjHacI)995400000000040854 035 $a(EXLCZ)995400000000040854 100 $a20230630d2021 uy 0 101 0 $aeng 135 $aur||||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aAdvances in complex valvular disease /$fedited by Michael S. Firstenberg, Imran Khan 210 1$aLondon :$cIntechOpen,$d[2021] 210 4$dİ2021 215 $a1 online resource (166 pages) $cillustrations 311 $a1-83968-424-0 320 $aIncludes bibliographical references. 330 $aAs the diagnostic and therapeutic tools for the management of complex cardiac valve disease continue to evolve, the options for patients who previously had few choices continue to expand. Such advances have resulted in a renaissance in how Heart Teams approach problems and have been able to engage patients in shared decision-making conversations towards a common goal. While opportunities exist in the management of physiologically challenging congenital heart disease, the vast explosion of research and development in the area of aortic valve disease has offered new hope to patients for improving their quality and quantity of life. The goal of this text is to hopefully serve as a foundation for those who want to explore such topics in greater detail. 606 $aHeart valves$xDiseases 615 0$aHeart valves$xDiseases. 676 $a616.125 702 $aFirstenberg$b Michael S. 702 $aKhan$b Imran 801 0$bNjHacI 801 1$bNjHacl 906 $aBOOK 912 $a9910688467403321 996 $aAdvances in Complex Valvular Disease$92823441 997 $aUNINA